Literature DB >> 8496814

Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.

N Jaiswal1, E A Tallant, R K Jaiswal, D I Diz, C M Ferrario.   

Abstract

We determined the role of AT1 and AT2 angiotensin receptors as mediators of prostaglandin (PG) release and mobilization of intracellular Ca++ in cultures of porcine vascular smooth muscle cells (VSMC) with subtype-selective angiotensin (Ang) II receptor antagonists. The binding of [125I]Ang II to porcine VSMC showed an equilibrium constant (KD) of 0.52 nM and a binding capacity (Bmax) of 14.8 fmol/mg protein. Using the AT1 antagonists DuP 753, its metabolite EXP 3174, and L-158,809, [125I]Ang II binding was displaced in a clearly biphasic manner, indicating the presence of two binding sites. Consistent with this, the AT2 antagonist CGP 42112A also displayed a biphasic curve, whereas another AT2 antagonist, PD 123177, showed a 20% reduction in binding. Ang I, Ang II and Ang-(1-7) stimulated PGE2 as well as PGI2 synthesis in a dose-dependent pattern. Ang II but not Ang I or Ang-(1-7) also caused an increase in the intracellular concentration of Ca++. Ca++ mobilization by Ang II was blocked by the AT1 antagonist DuP 753, but not by the AT2 antagonists. Ang II- and Ang I-stimulated (10 nM) PG production was attenuated by all three AT1 antagonists. However, both CGP 42112A (100 nM) and PD 123177 (100 nM) also attenuated PG release in response to Ang II. The enhancement in PG release by Ang I (10 nM) was significantly reduced by CGP 42112A (100 nM), but not by PD 123177 (1 microM). Of the AT1 antagonists, only high doses of DuP 753 or L-158,809 partially reduced the Ang-(1-7)-induced release of PG. CGP 42112A was ineffective for blocking Ang-(1-7)-stimulated PG release. Ang-(1-7)-stimulated PGE2 and PGI2 production was significantly reduced by PD 123177. Unlike DuP 753 or L-158,809, but similar to the sarcosine antagonists, EXP 3174 (10 nM) abolished the angiotensin peptide-induced PG production. These data show that Ang I and Ang II stimulate PGE2 and PGI2 release via activation of both AT1 and AT2 receptors in porcine VSMC. Ang II stimulates intracellular Ca++ mobilization via activation of AT1 receptors only. Because Ang-(1-7) enhanced PGE2 and PGI2 release via activation of angiotensin receptors having greater affinity for PD 123177 than CGP 42112A, although CGP 42112A showed a greater ability to block the Ang I response, these data further suggest differences in these two compounds at AT2 receptors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496814

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

2.  Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.

Authors:  Matthew J Durand; Gábor Raffai; Brian D Weinberg; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-23       Impact factor: 4.733

Review 3.  Angiotensin peptides and lung cancer.

Authors:  Patricia E Gallagher; Katherine Cook; David Soto-Pantoja; Jyotsana Menon; E Ann Tallant
Journal:  Curr Cancer Drug Targets       Date:  2011-05       Impact factor: 3.428

4.  Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia.

Authors:  L Morgan; S Crawshaw; P N Baker; J F Brookfield; F Broughton Pipkin; N Kalsheker
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

5.  Estrogen Receptor-β Mediates Estradiol-Induced Pregnancy-Specific Uterine Artery Endothelial Cell Angiotensin Type-2 Receptor Expression.

Authors:  Jay S Mishra; Gigi M Te Riele; Qian-Rong Qi; Thomas J Lechuga; Kathirvel Gopalakrishnan; Dong-Bao Chen; Sathish Kumar
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

6.  Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.

Authors:  I Pörsti; M Hecker; E Bassenge; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

7.  Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors.

Authors:  Antonio J Magaldi; Katia R Cesar; Magali de Araújo; Ana C Simões e Silva; Robson A S Santos
Journal:  Pflugers Arch       Date:  2003-10-08       Impact factor: 3.657

8.  Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats.

Authors:  Amanda K Stennett; Xiaoying Qiao; Anthony E Falone; Vera V Koledova; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-16       Impact factor: 4.733

9.  Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats.

Authors:  Jay S Mishra; Kathirvel Gopalakrishnan; Sathish Kumar
Journal:  Biol Reprod       Date:  2018-11-01       Impact factor: 4.285

Review 10.  Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy.

Authors:  Christoph Schindler; Peter Bramlage; Wilhelm Kirch; Carlos M Ferrario
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.